An important cellular function of SIRT7 is regulation of the chromatin remodelling: it catalyses the selective deacetylation of lysine 18 on histone H3 (H3K18), an emerging histone biomarker of aggressive tumours and poor clinical outcome in patients with cancer. Here, SIRT7 is linked to neoplasm.